دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction
Matteo Pagnesi, MD,a, * Marco Metra, MD,a, * Alain Cohen-Solal, MD, PH D, b,c Christopher Edwards, BS, d Marianna Adamo, MD, a Daniela Tomasoni, MD, a Carolyn S.P. Lam, MD, P HD, e,f Ovidiu Chioncel, MD, P HD, g Rafael Diaz, MD,h Gerasimos Filippatos, MD, i Piotr Ponikowski, MD, P HD, j Karen Sliwa, MD, PH D, k Adriaan A. Voors, MD, PHD, f Antoine Kimmoun, MD, P HD, l Maria Novosadova, MD, d Koji Takagi, MD,d Marianela Barros, MD,d Albertino Damasceno, MD, P HD, m Hadiza Saidu, MBBS,n Etienne Gayat, MD, PH D, b,o Peter S. Pang, MD,p Jelena Celutkiene, MD, P HD, q Gad Cotter, MD,b,d Alexandre Mebazaa, MD, PH D, b,o Beth Davison, PHD
doi : 10.1016/j.jacc.2023.03.426
Volume 81, Issue 22, 6 June 2023, Pages 2131-2144
Acute heart failure (AHF) is associated with a poor prognosis regardless of left ventricular ejection fraction (LVEF). STRONG-HF showed the efficacy and safety of a strategy of rapid uptitration of oral treatment for heart failure (HF) and close follow-up (high-intensity care), compared with usual care, in patients recently hospitalized for AHF and enrolled independently from their LVEF.
Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure: Strong Impact Across Ejection Fraction Spectrum∗
Gregg C. Fonarow, MD,a Stephen J. Greene, MD
doi : 10.1016/j.jacc.2023.04.006
Volume 81, Issue 22, 6 June 2023, Pages 2145-2148
Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation
Matthew J. Lewis, MD, MPH,a Leigh C. Reardon, MD,b Jamil Aboulhosn, MD,b Christiane Haeffele, MD,c Sharon Chen, MD, MPH,c Yuli Kim, MD,d Stephanie Fuller, MD,e Lisa Forbess, MD,f Laith Alshawabkeh, MD, MSCI, g Marcus A. Urey, MD, g Wendy M. Book, MD, h Fred Rodriguez III, MD, h Jonathan N. Menachem, MD,i Daniel E. Clark, MD, MPH,i Anne Marie Valente, MD,j Matthew Carazo, MD, j Alexander Egbe, MD, MPH,k Heidi M. Connolly, MD,k Eric V. Krieger, MD,l Jilian Angiulo, BS, l Ari Cedars, MD, m Jong Ko, MA,m Roni M. Jacobsen, MD,n Michael G. Earing, MD,n Jonathan W. Cramer, MD, o Peter Ermis, MD, p Christopher Broda, MD, p Natalia Nugaeva, P HD, q Heather Ross, MD,q Jordan D. Awerbach, MD, MPH,r Richard A. Krasuski, MD,s Marlon Rosenbaum, MDa
doi : 10.1016/j.jacc.2023.03.421
Volume 81, Issue 22, 6 June 2023, Pages 2149-2160
The impact of Fontan-associated liver disease (FALD) on post-transplant mortality and indications for combined heart-liver transplant (CHLT) in adult Fontan patients remains unknown.
Morbidity and Mortality in Adult Fontan Patients After Heart or Combined Heart-Liver Transplantation
Matthew J. Lewis, MD, MPH,a Leigh C. Reardon, MD,b Jamil Aboulhosn, MD,b Christiane Haeffele, MD,c Sharon Chen, MD, MPH,c Yuli Kim, MD,d Stephanie Fuller, MD,e Lisa Forbess, MD,f Laith Alshawabkeh, MD, MSCI, g Marcus A. Urey, MD, g Wendy M. Book, MD, h Fred Rodriguez III, MD, h Jonathan N. Menachem, MD,i Daniel E. Clark, MD, MPH,i Anne Marie Valente, MD,j Matthew Carazo, MD, j Alexander Egbe, MD, MPH,k Heidi M. Connolly, MD,k Eric V. Krieger, MD,l Jilian Angiulo, BS, l Ari Cedars, MD, m Jong Ko, MA,m Roni M. Jacobsen, MD,n Michael G. Earing, MD,n Jonathan W. Cramer, MD, o Peter Ermis, MD, p Christopher Broda, MD, p Natalia Nugaeva, P HD, q Heather Ross, MD,q Jordan D. Awerbach, MD, MPH,r Richard A. Krasuski, MD,s Marlon Rosenbaum, MD
doi : 10.1016/j.jacc.2023.03.422
Volume 81, Issue 22, 6 June 2023, Pages 2161-2171
An increasing number of adult Fontan patients require heart transplantation (HT) or combined heart-liver transplant (CHLT); however, data regarding outcomes and optimal referral time remain limited.
The Last Stage of the Fontan Operation?∗
Karen Stout, MD, Jonathan Buber, MD
doi : 10.1016/j.jacc.2023.04.023
Volume 81, Issue 22, 6 June 2023, Pages 2172-2174
Normative Echocardiographic Left Ventricular Parameters and Reference Intervals in Infants
R. Ottilia B. V?gg, MD, PHD, a,b Anne-Sophie Sillesen, MD, P HD, a Jan Wohlfahrt, MSC , DMSC ,b Christian Pihl, MD, PHD, a Anna Axelsson Raja, MD, P HD, c Niels Vejlstrup, MD, PHD, c Jakob B. Norsk, MD,a Eleni Elia, MS C, P HD, d Lynn A. Sleeper, SCD, d Steven D. Colan, MD,d Kasper K. Iversen, MD, DMSC ,a,e Heather A. Boyd, P HD, b, * Henning Bundgaard, MD, DMS
doi : 10.1016/j.jacc.2023.03.423
Volume 81, Issue 22, 6 June 2023, Pages 2175-2185
In pediatric echocardiography, reference intervals are required to distinguish normal variation from pathology. Left ventricular (LV) parameters are particularly important predictors of clinical outcome. However, data from healthy newborns are limited, and current reference intervals provide an inadequate approximation of normal reference ranges.
Complexities of Normative Database for Neonatal Echocardiography: The Quest for Perfection Continues∗
Ritu Sachdeva, MBBS
doi : 10.1016/j.jacc.2023.04.004
Volume 81, Issue 22, 6 June 2023, Pages 2186-2188
Multidisciplinary Critical Care Management of Electrical Storm: JACC State-of-the-Art Review
Jacob C. Jentzer, MD, a Peter A. Noseworthy, MD, a Anthony H. Kashou, MD, a Adam M. May, MD,b Jonathan Chrispin, MD,c Rajesh Kabra, MD, d Kelly Arps, MD,e Vanessa Blumer, MD, f James E. Tisdale, PHARMD, g,h Michael A. Solomon, MD, MBA, i,j on behalf of the American College of Cardiology Critical Care Cardiology and Electrophysiology Sections
doi : 10.1016/j.jacc.2023.03.424
Volume 81, Issue 22, 6 June 2023, Pages 2189-2206
Electrical storm (ES) reflects life-threatening cardiac electrical instability with 3 or more ventricular arrhythmia episodes within 24 hours. Identification of underlying arrhythmogenic cardiac substrate and reversible triggers is essential, as is interrogation and programming of an implantable cardioverter-defibrillator, if present. Medical management includes antiarrhythmic drugs, beta-adrenergic blockade, sedation, and hemodynamic support.
Innovation in Cardiovascular Care Delivery
Edward T.A. Fry, MD, MACC, Immediate Past President, American College of Cardiology Thomas M. Maddox, MD, FACC, Board of Trustees, American College of Cardiology Ami B. Bhatt, MD, FACC, Chief Innovation Officer,
doi : 10.1016/j.jacc.2023.04.026
Volume 81, Issue 22, 6 June 2023, Pages 2207-2209
Mental Stress Testing in Women With Angina and No Obstructive Coronary Artery Disease
Huan Ma, MD, PhD Wei Jiang, MD Lan Guo, MD, PhD Han Yin, MD Haochen Wang, MD Yuting Liu, MD Bingqing Bai, MD Quanjun Liu, MD Shuxia Wang, MD, PhD *Qingshan Geng, MD, PhD
doi : 10.1016/j.jacc.2023.03.427
Volume 81, Issue 22, 6 June 2023, Pages 2210-2211
DAPT Shortening After Complex PCI: Examining the Fine Print
Anastasios Apostolos, MD Georgios Vasilagkos, MD Konstantinos Toutouzas, MD, PhD Grigorios Tsigkas, MD, PhD
doi : 10.1016/j.jacc.2023.02.053
Volume 81, Issue 22, 6 June 2023, Page e191
Reply: DAPT Shortening After Complex PCI: Examining the Fine Print
Marco Valgimigli, MD, PhD
doi : 10.1016/j.jacc.2023.03.425
Felice Gragnano, MD, PhD Roxana Mehran, MD Paolo Calabr?, MD, PhDMarco Valgimigli, MD, PhD
